The experiences of new mothers accessing feeding support for infants with down syndrome during the COVID-19 pandemic.

Infants with Down syndrome are more likely to experience feeding problems and mothers are likely to require more feeding support than mothers of typically developing infants. During the COVID-19 pandemic, many feeding support services changed from face-to-face to online, which impacted some maternal feeding experiences negatively, but no studies to date have explored the impact for mothers of infants with Down syndrome. Thematic analysis was conducted on semi-structured interviews from thirteen new mothers of infants (aged 8-17 months) with Down syndrome in the UK. Three superordinate themes were generated: (1) Every baby with Down syndrome has a unique journey, (2) There's no point asking, they won't know, (3) Lack of in-person support. Many mothers expressed frustrations over health professionals' lack of Down syndrome specific knowledge resulting in unmet needs, further magnified due to the nature of the virtual support being offered. Moreover, mothers struggled with reduced social support from other mothers when encountering feeding problems. These results hold real-world implications for health professionals who could provide more specialised face-to-face feeding support to mothers of infants with Down syndrome. This should be prioritised for children's overall development and mothers' wellbeing.

A randomised controlled trial of energetic activity for depression in young people (READY): a multi-site feasibility trial protocol.

BACKGROUND: Prevalence of depression is increasing in young people, and there is a need to develop and evaluate behavioural interventions which may provide benefits equal to or greater than talking therapies or pharmacological alternatives. Exercise could be beneficial for young people living with depression, but robust, large-scale trials of effectiveness and the impact of exercise intensity are lacking. This study aims to test whether a randomised controlled trial (RCT) of an intervention targeting young people living with depression is feasible by determining whether it is possible to recruit and retain young people, develop and deliver the intervention as planned, and evaluate training and delivery. METHODS: The design is a three-arm cluster randomised controlled feasibility trial with embedded process evaluation. Participants will be help-seeking young people, aged 13-17 years experiencing mild to moderate low mood or depression, referred from three counties in England. The intervention will be delivered by registered exercise professionals, supported by mental health support workers, twice a week for 12 weeks. The three arms will be high-intensity exercise, low-intensity exercise, and a social activity control. All arms will receive a 'healthy living' behaviour change session prior to each exercise session and the two exercise groups are energy matched. The outcomes are referral, recruitment, and retention rates; attendance at exercise sessions; adherence to and ability to reach intensity during exercise sessions; proportions of missing data; adverse events, all measured at baseline, 3, and 6 months; resource use; and reach and representativeness. DISCUSSION: UK National Health Service (NHS) policy is to provide young people with advice about using exercise to help depression but there is no evidence-based exercise intervention to either complement or as an alternative to medication or talking therapies. UK National Institute for Health and Care Excellence (NICE) guidelines suggest that exercise can be an effective treatment, but the evidence base is relatively weak. This feasibility trial will provide evidence about whether it is feasible to recruit and retain young people to a full RCT to assess the effectiveness and cost-effectiveness of an exercise intervention for depression. TRIAL REGISTRATION: ISRCTN, ISRCTN66452702 . Registered 9 April 2020.

The Behavioral Response of Blattella germanica (Blattodea: Ectobiidae) Exposed to DEET Varies Throughout Its Life Cycle.

The German cockroach, Blattella germanica L., is a hemimetabolous insect pest of economical and medical importance. N,N-diethyl-3-methylbenzamide (DEET) is an insect repellent whose effect on this species has received very little attention. The objective of this work was to determine whether the behavioral response of B. germanica to DEET varies along its life cycle. DEET repellence was assessed in small, medium, and large nymphs, and in adults of both sexes, all originated from the same laboratory colony (CIPEIN). The experimental arena consisted in a piece of filter paper treated with repellent on one half (195 µg/cm2) and solvent alone on the other half. A cockroach was placed on the filter paper, and its behavior was filmed. An image analyzer was used to quantify how long the insect spent on each side of the paper. As a control, a cockroach was exposed to a piece of filter paper treated with solvent (acetone) alone. Each assay was repeated independently six times. Distribution coefficient (DC) values were calculated, a parameter that ranges between 0 (attraction) and 1 (repellence). Small nymphs were more sensitive to DEET (mean DC = 0.93). The mean DC values of the other groups varied between 0.62 (medium nymphs) and 0.71 (male adults). The group of medium nymphs was the only one whose behavior was not significantly altered by exposure to DEET. The results show the importance of assessing insect repellents at different stages of the insect's life cycle in order to obtain a complete panorama of its effect.

Epidemiological surveillance of staphylococcal resistance.

The aim of our investigation was to characterize better the possible changes in staphylococcal susceptibility to some antimicrobial agents. We considered the staphylococcal strains isolated between June 1986 and June 1989 and held responsible for proved bacterial infections. In this relatively short time we observed a moderate increase in methicillin resistance. Compared with methicillin-sensitive strains, methicillin-resistant isolates showed minor susceptibility to most antimicrobial agents; nevertheless, vancomycin, teicoplanin, cefamandole, imipenem, fluoroquinolones and netilmicin, according to our results, appear at present the most reliable antistaphylococcal antibiotics.